FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2261871796> ?p ?o ?g. }

• W2261871796 endingPage "250" @default.
• W2261871796 startingPage "243" @default.
• W2261871796 abstract "ObjectiveSince dyslipidaemia is one of the most important risk factors for coronary heart disease (CHD), lowering of LDL-cholesterol (LDL-C) causes significant reduction in morbidity and mortality, particularly in patients with established CHD. The aim of this survey was to assess how statins were prescribed in CHD patients at discharge after a coronary event from hospitals throughout Europe and how the intake of these drugs was reported by the patients when they were seen more than one year later in relationship with their achieved LDL-C levels.Methods6648 CHD patients' data from centres in 24 European countries were gathered using standardized methods. Lipid measurements were performed in one central laboratory. Patients were divided in three groups: high-intensity statin therapy, moderate or low intensity statin therapy and no statin therapy at all.Results90.4% CHD patients were on statin therapy at the time of discharge from the hospital which decreased to 86% one year later. Only 37.6% of these patients were prescribed a high-intensity statin at discharge which even decreased to 32.7% later. In only 6 countries (all of them high-income countries) the number of patients on a high-intensity statin therapy increased substantially after the hospital discharge. It is worrying that statin therapy was discontinued in 11.6% and that only 19.3% of all CHD patients achieved target values of LDL-C < 1.8 mmol/L at the time of interview.ConclusionsToo many CHD patients with dyslipidaemia are still inadequately treated and most of these patients on statin therapy are not achieving the treatment targets. Therapeutic control of LDL-C is clearly related to the intensity of lipid lowering drug regimen after the CHD event indicating that a considerable potential still exists throughout Europe to reduce CHD mortality and morbidity rates through more efficient LDL-C lowering." @default.
• W2261871796 created "2016-06-24" @default.
• W2261871796 creator A5010590406 @default.
• W2261871796 creator A5023972061 @default.
• W2261871796 creator A5031972364 @default.
• W2261871796 creator A5045816461 @default.
• W2261871796 creator A5055188417 @default.
• W2261871796 creator A5065701334 @default.
• W2261871796 creator A5075242638 @default.
• W2261871796 creator A5085957100 @default.
• W2261871796 date "2016-03-01" @default.
• W2261871796 modified "2023-10-16" @default.
• W2261871796 title "Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries – Findings from the EUROASPIRE IV survey" @default.
• W2261871796 cites W1520609538 @default.
• W2261871796 cites W1587128794 @default.
• W2261871796 cites W1594296636 @default.
• W2261871796 cites W1816597323 @default.
• W2261871796 cites W1948458971 @default.
• W2261871796 cites W1972661406 @default.
• W2261871796 cites W1974005985 @default.
• W2261871796 cites W1980114153 @default.
• W2261871796 cites W1996398939 @default.
• W2261871796 cites W2019071303 @default.
• W2261871796 cites W2024050333 @default.
• W2261871796 cites W2048844603 @default.
• W2261871796 cites W2049151343 @default.
• W2261871796 cites W2054604929 @default.
• W2261871796 cites W2066956248 @default.
• W2261871796 cites W2070732762 @default.
• W2261871796 cites W2079134517 @default.
• W2261871796 cites W2080152964 @default.
• W2261871796 cites W2084219024 @default.
• W2261871796 cites W2088303275 @default.
• W2261871796 cites W2093073697 @default.
• W2261871796 cites W2097319856 @default.
• W2261871796 cites W2101185950 @default.
• W2261871796 cites W2112936129 @default.
• W2261871796 cites W2117828002 @default.
• W2261871796 cites W2127469535 @default.
• W2261871796 cites W2134216598 @default.
• W2261871796 cites W2138848829 @default.
• W2261871796 cites W2144577176 @default.
• W2261871796 cites W2154836846 @default.
• W2261871796 cites W2159326935 @default.
• W2261871796 cites W2164089346 @default.
• W2261871796 cites W2170096228 @default.
• W2261871796 cites W3150330975 @default.
• W2261871796 cites W4242668396 @default.
• W2261871796 doi "https://doi.org/10.1016/j.atherosclerosis.2016.01.018" @default.
• W2261871796 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26812002" @default.
• W2261871796 hasPublicationYear "2016" @default.
• W2261871796 type Work @default.
• W2261871796 sameAs 2261871796 @default.
• W2261871796 citedByCount "153" @default.
• W2261871796 countsByYear W22618717962016 @default.
• W2261871796 countsByYear W22618717962017 @default.
• W2261871796 countsByYear W22618717962018 @default.
• W2261871796 countsByYear W22618717962019 @default.
• W2261871796 countsByYear W22618717962020 @default.
• W2261871796 countsByYear W22618717962021 @default.
• W2261871796 countsByYear W22618717962022 @default.
• W2261871796 countsByYear W22618717962023 @default.
• W2261871796 crossrefType "journal-article" @default.
• W2261871796 hasAuthorship W2261871796A5010590406 @default.
• W2261871796 hasAuthorship W2261871796A5023972061 @default.
• W2261871796 hasAuthorship W2261871796A5031972364 @default.
• W2261871796 hasAuthorship W2261871796A5045816461 @default.
• W2261871796 hasAuthorship W2261871796A5055188417 @default.
• W2261871796 hasAuthorship W2261871796A5065701334 @default.
• W2261871796 hasAuthorship W2261871796A5075242638 @default.
• W2261871796 hasAuthorship W2261871796A5085957100 @default.
• W2261871796 hasBestOaLocation W22618717961 @default.
• W2261871796 hasConcept C126322002 @default.
• W2261871796 hasConcept C164705383 @default.
• W2261871796 hasConcept C2776839432 @default.
• W2261871796 hasConcept C3018906752 @default.
• W2261871796 hasConcept C500440147 @default.
• W2261871796 hasConcept C71924100 @default.
• W2261871796 hasConceptScore W2261871796C126322002 @default.
• W2261871796 hasConceptScore W2261871796C164705383 @default.
• W2261871796 hasConceptScore W2261871796C2776839432 @default.
• W2261871796 hasConceptScore W2261871796C3018906752 @default.
• W2261871796 hasConceptScore W2261871796C500440147 @default.
• W2261871796 hasConceptScore W2261871796C71924100 @default.
• W2261871796 hasLocation W22618717961 @default.
• W2261871796 hasLocation W22618717962 @default.
• W2261871796 hasLocation W22618717963 @default.
• W2261871796 hasOpenAccess W2261871796 @default.
• W2261871796 hasPrimaryLocation W22618717961 @default.
• W2261871796 hasRelatedWork W2011347913 @default.
• W2261871796 hasRelatedWork W2049397185 @default.
• W2261871796 hasRelatedWork W2052321117 @default.
• W2261871796 hasRelatedWork W2073151595 @default.
• W2261871796 hasRelatedWork W2074833529 @default.
• W2261871796 hasRelatedWork W2159512267 @default.
• W2261871796 hasRelatedWork W2304633692 @default.
• W2261871796 hasRelatedWork W2386386007 @default.
• W2261871796 hasRelatedWork W2399063111 @default.

• next